ArteraAI vs Pearl
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
ArteraAI compared with Pearl
| Detail | 
ArteraAI | 
Pearl |
|---|
| What it does | Personalized precision medicine powered by AI for cancer therapy
| FDA-cleared dental AI software that detects more disease and helps dental practices deliver smarter patient care
|
|---|
| Stage | Not given
| Established
|
|---|
| Founded | Not given
| 2019
|
|---|
| Based in | US
| Not given
|
|---|
| Pricing model | Contact for pricing
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
| - Second Opinion® - AI detection of pathologies in 2D X-rays and 3D CBCT imagery
- Practice Intelligence® - Data-driven insights for practice growth
- RCM™ - Insurance verification and cleaner claim submissions
- Calibrate® - AI-guided clinical training for consistency
- Second Opinion 3D® - Fast and easy CBCT review for specialists and general dentists
- Pearl Voice™ - Ambient voice AI for clinical notes and perio charting
- 37% more disease detection than manual review
- Integration with 40+ imaging and practice management systems
- FDA clearance in 26+ countries
- Patient education and treatment acceptance tools
|
|---|
| What makes it different | - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
| - Only FDA-cleared AI supporting both 2D X-rays and 3D CBCT diagnostic workflows
- Detects 37% more disease than traditional methods
- Trusted by 29,000+ dental practices globally
- Operates in 120+ countries with 26+ regulatory clearances
- Integrated platform spanning diagnosis, practice intelligence, and revenue cycle management
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 57 ● no change since last check | 63 ▲ +1 (up) since last check |
|---|
| Trust Flow (Majestic) | 15 | 25 |
|---|
| Citation Flow (Majestic) | 27 | 41 |
|---|
| Referring domains (Majestic) | 285 | 901 |
|---|
4 details filled in for both companies.
More alternatives to ArteraAI More alternatives to Pearl